104
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Prognostic Significance of Initial r-Wave in Leads V1 and aVR Before PTSMA in Patients with Hypertrophic Obstructive Cardiomyopathy

ORCID Icon &
Pages 9589-9598 | Published online: 10 Dec 2021

References

  • Ho CY, Lopez B, Coelho-Filho OR, et al. Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med. 2010;363:552–563. doi:10.1056/NEJMoa1002659
  • Steggerda RC, Damman K, Balt JC, et al. Periprocedural complications and long-term outcome after alcohol septal ablation versus surgical myectomy in hypertrophic obstructive cardiomyopathy. JACC Cardiovasc Interv. 2014;7(11):1227–1234. doi:10.1016/j.jcin.2014.05.023
  • Faber L, Welge D, Fassbender D, et al. One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol. 2007;96(12):864–873. doi:10.1007/s00392-007-0578-9
  • Maekawa Y, Jinzaki M, Anzai A, et al. Successful second attempt multidetector computed tomography-guided percutaneous transluminal septal myocardial ablation for an octogenarian with hypertrophic obstructive cardiomyopathy. Int J Cardiol. 2014;176(3):e131–e132. doi:10.1016/j.ijcard.2014.07.211
  • Chang SM, Lakkis NM, Franklin J, et al. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy. Circulation. 2004;109(7):824–827. doi:10.1161/01.CIR.0000117089.99918.5A
  • Henein MY, O’Sullivan CA, Ramzy IS, et al. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999;34(4):1117–1122. doi:10.1016/S0735-1097(99)00332-0
  • Kappenberger L, Linde C, Daubert C, et al. Pacing in hypertrophic obstructive cardiomyopathy. A randomized crossover study. PIC Study Group. Eur Heart J. 1997;18:1249–1256. doi:10.1093/oxfordjournals.eurheartj.a015435
  • Spach MS, Barr RC. Ventricular intramural and epicardial potential distributions during ventricular activation and repolarization in the intact dog. Circ Res. 1975;37:243–257. doi:10.1161/01.RES.37.2.243
  • Durrer D, van Dam RT, Freud GE, et al. Total excitation of the isolated human heart. Circulation. 1970;41(6):899–912. doi:10.1161/01.CIR.41.6.899
  • Gurjarpadhye A, Hewett KW, Justus C, et al. Cardiac neural crest ablation inhibits compaction and electrical function of conduction system bundles. Am J Physiol Heart Circ Physiol. 2007;292(3):H1291–H1300. doi:10.1152/ajpheart.01017.2006
  • Elliott PM, Anastasakis A, Borger MA, et al. 2014 ESC guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J. 2014;35:2733–2779.
  • Nagueh SF, Bierig SM, Budoff MJ, et al. American society of echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American society of nuclear cardiology, society for cardiovascular magnetic resonance, and society of cardiovascular computed tomography. J Am Soc Echocardiogr. 2011;24:473–498. doi:10.1016/j.echo.2011.03.006
  • Zhang C, Liu R, Yuan J, et al. Significance and determinants of cardiac troponin I in patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2015;116(11):1744–1751. doi:10.1016/j.amjcard.2015.09.006
  • Bennett JA, Riegel B, Bittner V, et al. Validity and reliability of the NYHA classes for measuring research outcomes in patients with cardiac disease. Heart Lung. 2002;31(4):262–270. doi:10.1067/mhl.2002.124554
  • Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet. 1995;346(8969):211–214. doi:10.1016/S0140-6736(95)91267-3
  • Sorajja P, Ommen SR, Holmes DJ, et al. Survival after alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Circulation. 2012;126(20):2374–2380. doi:10.1161/CIRCULATIONAHA.111.076257
  • Veselka J, Krejci J, Tomasov P, et al. Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population. Eur Heart J. 2014;35:2040–2045. doi:10.1093/eurheartj/eht495
  • Batzner A, Pfeiffer B, Neugebauer A, et al. Survival after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2018;72(24):3087–3094. doi:10.1016/j.jacc.2018.09.064
  • Steggerda RC, Balt JC, Damman K, et al. Predictors of outcome after alcohol septal ablation in patients with hypertrophic obstructive cardiomyopathy. Special interest for the septal coronary anatomy. Neth Heart J. 2013;21(11):504–509. doi:10.1007/s12471-013-0453-4
  • Valeti US, Nishimura RA, Holmes DR, et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;49(3):350–357. doi:10.1016/j.jacc.2006.08.055
  • Tamura A, Kataoka H, Mikuriya Y. Electrocardiographic findings in a patient with pure septal infarction. Br Heart J. 1991;65:166–167. doi:10.1136/hrt.65.3.166
  • Xiao HB, Gibson DG. Absent septal q wave: a marker of the effects of abnormal activation pattern on left ventricular diastolic function. Br Heart J. 1994;72:45–51. doi:10.1136/hrt.72.1.45
  • Seggewiss H, Gleichmann U, Faber L, et al. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol. 1998;31(2):252–258. doi:10.1016/S0735-1097(97)00508-1
  • Ruzyllo W, Chojnowska L, Demkow M, et al. Left ventricular outflow tract gradient decrease with non-surgical myocardial reduction improves exercise capacity in patients with hypertrophic obstructive cardiomyopathy. Eur Heart J. 2000;21:770–777. doi:10.1053/euhj.1999.1905
  • Chojnowska L, Ruzyllo W, Witkowski A, et al. Early and long-term results of non-surgical septal reduction in patients with hypertrophic cardiomyopathy. Kardiol Pol. 2003;59:269–282.
  • Kim JJ, Lee CW, Park SW, et al. Improvement in exercise capacity and exercise blood pressure response after transcoronary alcohol ablation therapy of septal hypertrophy in hypertrophic cardiomyopathy. Am J Cardiol. 1999;83:1220–1223. doi:10.1016/S0002-9149(99)00063-6